Table 2.
Differences in primary and secondary observations between groups (n=12)
| Variable | LCRT group (n=4) | TNT-RAPIDO group (n=4) | Upfront group (n=4) | P-value |
|---|---|---|---|---|
| Primary observation (assessment of videos) | ||||
| Visual analog score (cm) | 3.2 (1.7–5.1) | 4.6 (3.6–8.0) | 4.1 (1.2–6.1) | 0.12 |
| Proportion of surgeons who correctly identified treatment category (%) | 29 | 71 | 25 | 0.01 |
| Secondary observation (objective measure) | ||||
| Operative time (min) | 278 (286–365) | 350 (283–520) | 283 (206–335) | 0.33 |
| Duration of hospitalization (day) | 5 (4–8) | 5 (4–5) | 6 (5–7) | 0.27 |
| 30-day Morbidity | 1a | 0 | 0 | 0.34 |
| 30-day Mortality | 0 | 0 | 0 | >0.99 |
Values are presented as median (range) or number only.
LCRT, long-course chemoradiotherapy; TNT, total neoadjuvant therapy; RAPIDO, Rectal Cancer and Preoperative Induction Therapy Followed by Dedicated Operation.
a
Blood transfusion; morbidity rate, 25%.